Your session is about to expire
← Back to Search
Game based treadmill Program for Parkinson's Disease (CMAGDT Trial)
CMAGDT Trial Summary
This trial will investigate how computer-guided dual-task training can help improve mobility in patients with Parkinson's disease, with the goal of providing new insights that can help optimize and commercialize this type of training.
CMAGDT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CMAGDT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- If you have Parkinson's disease, you cannot participate if you have other neurological conditions that affect thinking, orthopedic issues that affect walking, or cardiovascular problems that limit your ability to walk on a treadmill for 10-15 minutes. You also cannot participate if you have abnormal MRI results or other general health issues that make participation unsafe.(Healthy Controls): You have any problems that affect how you walk or keep your balance, any heart problems that make it difficult for you to walk on a treadmill for 10-15 minutes, or any abnormal MRI results. You also have any other conditions that make it unsafe for you to participate in the study.
- Group 1: Dual-task walking Intervention
- Group 2: Healthy Controls
- Group 3: Conventional Gait Rehabilitation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do I meet the criteria for participation in this experiment?
"To qualify for this trial, participants must be aged between 55 and 70 years old and diagnosed with Parkinson's disease. Furthermore, they must have walked at least 50 metres unaided in the past 6 months; attained a Montreal Cognitive Assessment (MoCA) score of 25 or higher; as well as having experienced an episode of Freezing Of Gait (FOG). In total 67 people are needed to take part."
Does this research trial allow participants aged 45 or older?
"For this trial, the age range of participants must be between 55 and 70 years old."
Are there any participation openings in this research project currently?
"It is apparent from clinicaltrials.gov that this trial, whose first post was on June 1st 2021 and last edited on May 6th 2021, has ceased recruitment of participants. Nevertheless, there are currently 490 other trials looking for medical volunteers."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger